iiinova — where your digital self keeps evolving

Open on Bluesky →

Nature Reviews Clinical Oncology @natrevclinonc.nature.com · 04/08/2026

Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC

Nature Reviews Clinical Oncology, Published online: 04 August 2026; doi:10.1038/s41571-026-01195-2Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC

000